JAK2 and acquired polycythemia vera: Since we used highly sensitive assays here to detect JAK2 V617F mutation and given that all our patients have been classified according to the WHO diagnostic criteria, the low positivity rate observed in PV and PMF patients is most likely due to the small sample size.